HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alyssa Panitch Selected Research

Inflammation (Inflammations)

1/2022Proteoglycans and proteoglycan mimetics for tissue engineering.
1/2022Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
10/2020Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle.
10/2020Thermoresponsive, hollow, degradable core-shell nanoparticles for intra-articular delivery of anti-inflammatory peptide.
1/2019Selectin-Targeting Peptide-Glycosaminoglycan Conjugates Modulate Neutrophil-Endothelial Interactions.
1/2017Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model.
1/2017Collagen-binding nanoparticles for extracellular anti-inflammatory peptide delivery decrease platelet activation, promote endothelial migration, and suppress inflammation.
10/2016Controlled release of anti-inflammatory peptides from reducible thermosensitive nanoparticles suppresses cartilage inflammation.
7/2015Dexamethasone Controlled Release on TGF-β1 Treated Vocal Fold Fibroblasts.
7/2013Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alyssa Panitch Research Topics

Disease

15Inflammation (Inflammations)
01/2022 - 04/2011
8Osteoarthritis
09/2021 - 10/2011
7Hyperplasia
01/2017 - 07/2004
6Fibrosis (Cirrhosis)
10/2020 - 03/2009
6Cicatrix (Scar)
07/2016 - 08/2004
5Wounds and Injuries (Trauma)
12/2021 - 02/2007
4Thrombosis (Thrombus)
10/2020 - 04/2011
4Spinal Cord Injuries (Spinal Cord Injury)
07/2016 - 02/2007
3Keloid
12/2010 - 03/2009
2Gliosis
07/2010 - 08/2004
1Reperfusion Injury
01/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Vascular Diseases (Vascular Disease)
01/2020
1Glaucoma
01/2019
1Pain (Aches)
10/2016
1Open-Angle Glaucoma (Glaucoma, Open Angle)
10/2014
1Cataract (Cataracts)
10/2014
1Retinal Detachment (Retinal Detachments)
10/2014
1Retinal Perforations
10/2014
1Vitreous Detachment (Posterior Vitreous Detachment)
10/2014
1Pulmonary Fibrosis (Fibrosing Alveolitis)
07/2013
1Weight Loss (Weight Reduction)
07/2011
1Chronic Pain
07/2011
1Infertility (Sterility)
07/2011
1Infections
04/2011
1Neoplasms (Cancer)
02/2010
1Macular Degeneration (Age-Related Maculopathy)
04/2009
1Hemolysis
05/2006

Drug/Important Bio-Agent (IBA)

13Peptides (Polypeptides)IBA
01/2022 - 07/2004
8CollagenIBA
01/2020 - 03/2009
5Proteins (Proteins, Gene)FDA Link
06/2014 - 07/2004
4Proteoglycans (Proteoglycan)IBA
01/2022 - 01/2013
4CytokinesIBA
12/2021 - 07/2011
4Mitogen-Activated Protein KinasesIBA
07/2013 - 07/2011
3HydrogelsIBA
01/2020 - 02/2007
3poly-N-isopropylacrylamideIBA
01/2017 - 04/2013
3Hyaluronic Acid (Hyaluronan)IBA
07/2016 - 02/2007
3Protein Kinases (Protein Kinase)IBA
01/2012 - 07/2011
2GlycosaminoglycansIBA
01/2022 - 02/2010
2SelectinsIBA
01/2022 - 01/2019
2Aggrecans (Aggrecan)IBA
02/2016 - 09/2013
2DecorinIBA
06/2014 - 01/2013
2MMI-0100IBA
01/2012 - 07/2011
2Phosphotransferases (Kinase)IBA
10/2011 - 12/2010
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
07/2010 - 02/2010
2Connective Tissue Growth FactorIBA
05/2009 - 03/2009
1IntegrinsIBA
12/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021
1EnzymesIBA
09/2021
1Polysaccharides (Glycans)IBA
01/2021
1Platelet-Derived Growth FactorIBA
01/2021
1MK2i peptideIBA
10/2020
1LigandsIBA
01/2020
1erucylphosphocholineIBA
01/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1VimentinIBA
01/2017
1Cadherins (E-Cadherin)IBA
01/2017
1Phosphates (Orthophosphate)IBA
07/2016
1Neuroprotective AgentsIBA
07/2016
1salicylhydroxamic acid (SHAM)IBA
07/2016
1lubricinIBA
12/2015
1LubricantsIBA
12/2015
1Biocompatible Materials (Biomaterials)IBA
09/2015
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
07/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
07/2015
1p38 Mitogen-Activated Protein KinasesIBA
07/2013
1MAP-kinase-activated kinase 2IBA
07/2013
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2013
1Bleomycin (Blenoxane)FDA LinkGeneric
07/2013
1LipopolysaccharidesIBA
08/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012
1Cell-Penetrating PeptidesIBA
10/2011
1Hydroxyproline (4 Hydroxyproline)IBA
07/2011
1Matrix Metalloproteinases (MMPs)IBA
01/2011
1Peptidoglycan (Murein)IBA
01/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
12/2010
1Fibronectins (Fibronectin)IBA
12/2010
1Dihydrotachysterol (AT 10)IBA
05/2009
1Collagen Type I (Type I Collagen)IBA
05/2009
1Retinal Pigments (Pigments, Visual)IBA
04/2009
1Small Heat-Shock ProteinsIBA
03/2009
1PhosphopeptidesIBA
03/2009
1AZX 100IBA
03/2009
1PolymersIBA
02/2007
1Collagenases (Collagenase)FDA Link
05/2006
1ThrombinFDA Link
05/2006
1Heparin Lyase (heparin lyase)IBA
05/2006
1GelsIBA
05/2006

Therapy/Procedure

9Therapeutics
12/2021 - 02/2007
1Ligation
01/2022
1Intra-Articular Injections
10/2020
1Transplantation
01/2020
1Injections
01/2020
1Traction
10/2014
1Percutaneous Coronary Intervention
08/2014
1Operative Surgical Procedures
07/2011
1Stents
04/2011